相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors
Beata Chertok et al.
BIOMATERIALS (2008)
Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments
Arnaud Beduneau et al.
BIOMATERIALS (2007)
Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro
Youssef Jallouli et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Targeting the central nervous system:: In vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123
G. Tosi et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods:: 2-DE, CE and protein Lab-on-chip® system
Hyun Ryoung Kim et al.
ELECTROPHORESIS (2007)
Drug delivery strategies for poorly water-soluble drugs
Alfred Fahr et al.
EXPERT OPINION ON DRUG DELIVERY (2007)
Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres
J. L. Arias et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle
Wei Lu et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells:: Role of apolipoproteins in receptor-mediated endocytosis
Hyun R. Kim et al.
BIOMACROMOLECULES (2007)
Nanoparticles - a historical perspective
Joerg Kreuter
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier
Gabriel A. Silva
SURGICAL NEUROLOGY (2007)
Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells
H. Ryoung Kim et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery
Christine Vauthier et al.
JOURNAL OF DRUG TARGETING (2007)
Glycosylation improves the central effects of DAMGO
John J. Lowery et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
Blood-brain barrier delivery
William M. Pardridge
DRUG DISCOVERY TODAY (2007)
Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration
Wei Lu et al.
CANCER RESEARCH (2006)
Multifunctional nanocarriers
Vladimir P. Torchilin
ADVANCED DRUG DELIVERY REVIEWS (2006)
Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Phase 1 study of intra-arterial hepatic (IAH) delivery of doxorubicin-transdrug® (DT) for patients with advanced hepatocellular carcinoma (HCC)
P. Merle et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases
N. Popovic et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it?
Yaming Su et al.
EXPERT OPINION ON DRUG DELIVERY (2006)
Endocytosis at the blood-brain barrier: From basic understanding to drug delivery strategies
Mathew W. Smith et al.
JOURNAL OF DRUG TARGETING (2006)
Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats
A Ambruosi et al.
JOURNAL OF DRUG TARGETING (2006)
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures
Luca Costantino et al.
BIOMATERIALS (2006)
Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles
V Mishra et al.
JOURNAL OF DRUG TARGETING (2006)
Delivering drugs to the central nervous system: A medicinal chemistry or a pharmaceutical technology issue?
Maurizio Ricci et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease
C Roney et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier
L Costantino et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26
Y Aktas et al.
BIOCONJUGATE CHEMISTRY (2005)
Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery
W Lu et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Colloidal carriers and blood-brain barrier (BBB) translocation: A way to deliver drugs to the brain?
E Garcia-Garcia et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
A methodology to study intracellular distribution of nanoparticles in brain endothelial cells
E Garcia-Garcia et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles
G Tosi et al.
BIOMATERIALS (2005)
Medical application of functionalized magnetic nanoparticles
A Ito et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2005)
Targeted drug delivery to magnetic implants for therapeutic applications
BB Yellen et al.
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS (2005)
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
W Löscher et al.
PROGRESS IN NEUROBIOLOGY (2005)
Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer
R Kopelman et al.
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS (2005)
Glycosylated neuropeptides: A new vista for neuropsychopharmacology?
R Polt et al.
MEDICINAL RESEARCH REVIEWS (2005)
Body distribution of polysorbate-80 and doxorubicin-loaded [C-14]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats
A Ambruosi et al.
JOURNAL OF DRUG TARGETING (2005)
Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Paclitaxel nanoparticles for the potential treatment of brain tumors
JM Koziara et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain
WQ Sun et al.
BIOMATERIALS (2004)
Drug delivery systems for brain tumor therapy
J Rautio et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
New technologies for drug delivery across the blood brain barrier
AV Kabanov et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles
SCJ Steiniger et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Nanoparticle surface charges alter blood-brain barrier integrity and permeability
PR Lockman et al.
JOURNAL OF DRUG TARGETING (2004)
Nanogels for oligonucleotide delivery to the brain
SV Vinogradov et al.
BIOCONJUGATE CHEMISTRY (2004)
Brain uptake of thiamine-coated nanoparticles
PR Lockman et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles
C Vauthier et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis
AK Gupta et al.
IEEE TRANSACTIONS ON NANOBIOSCIENCE (2003)
Evaluation of blood-brain barrier thiamine efflux using the in situ rat brain perfusion method
PR Lockman et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Applications of magnetic nanoparticles in biomedicine
QA Pankhurst et al.
JOURNAL OF PHYSICS D-APPLIED PHYSICS (2003)
In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles
PR Lockman et al.
PHARMACEUTICAL RESEARCH (2003)
Accelerated clearance of a second injection of PEGylated liposomes in mice
T Ishida et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters
MO Oyewumi et al.
BIOCONJUGATE CHEMISTRY (2003)
Direct evidence that polysorbate-80-coated poly( butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles
J Kreuter et al.
PHARMACEUTICAL RESEARCH (2003)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Accelerated clearance of PEGylated liposomes in rats after repeated injections
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2003)
In situ blood-brain barrier transport of nanoparticles
JM Koziara et al.
PHARMACEUTICAL RESEARCH (2003)
Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting
I Brigger et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway
ZM Qian et al.
PHARMACOLOGICAL REVIEWS (2002)
Synthesis of pegylated immunonanoparticles
JC Olivier et al.
PHARMACEUTICAL RESEARCH (2002)
Biodegradable nanoparticles for drug delivery and targeting
ML Hans et al.
CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE (2002)
Reduced folate carrier transports thiamine monophosphate: an alternative route for thiamine delivery into mammalian cells
RB Zhao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier
J Kreuter et al.
JOURNAL OF DRUG TARGETING (2002)
Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat
P Calvo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Drug and gene targeting to the brain with molecular Trojan horses
WM Pardridge
NATURE REVIEWS DRUG DISCOVERY (2002)
Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells
SV Vinogradov et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases
P Calvo et al.
JOURNAL OF NEUROSCIENCE METHODS (2001)
Occludin expression in microvessels of neoplastic and non-neoplastic human brain
MC Papadopoulos et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2001)
Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery
P Calvo et al.
PHARMACEUTICAL RESEARCH (2001)
PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats
YP Li et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Nanoparticulate systems for brain delivery of drugs
J Kreuter
ADVANCED DRUG DELIVERY REVIEWS (2001)
The role of plasma proteins in brain targeting:: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles
A Gessner et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)
Biodegradable polymeric nanoparticles as drug delivery devices
KS Soppimath et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: Production, colloidal properties and biological performance
S Stolnik et al.
JOURNAL OF DRUG TARGETING (2001)
Vascular microenvironment in gliomas
P Vajkoczy et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG):: influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption
R Gref et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2000)
In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans
T Siegal et al.
JOURNAL OF NEUROSURGERY (2000)
Non-ionic detergent Tween 80 modulates VP-16 resistance in classical multidrug resistant K562 cells via enhancement of VP-16 influx
T Yamazaki et al.
CANCER LETTERS (2000)
Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system
A Friese et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
分享论文
